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ABSTRACT
Objective: To analyze hypertension and its relationship with the causes of death 
identified by the autopsy. Method: Cross-sectional study analyzed 356 participants 
belonging to the Brazilian Aging Brain Study Group, over 50 years of age, autopsied 
at the Sao Paulo Autopsy Service between 2004 to 2014. A clinical interview was 
conducted with the informant of the deceased. Hypertension was defined by reporting 
the disease and/or use of antihypertensive medication, by the informant of the deceased. 
Descriptive analyzes and bivariate and multivariable associations were performed. 
Results: The prevalence of hypertension was 66.2% and it was the second leading cause 
of death (25.6%) identified by autopsy, preceded by atherosclerosis (37.8%). The variables 
associated with hypertension were: female gender (OR=2.30 (1.34-3.90)); living with 
partner [OR=0.55 (0.32-0.92)]; Body Mass Index [OR=1.14 (1.08-1.22)] and history of 
diabetes [OR=2.39 (1.34-4.27)]. Conclusion: The prevalence of hypertension was high, 
and it was the second most common underlying cause of death. The gold standard for the 
definition of cause of death, the autopsy, shows important results, which confirmed the 
relevance of hypertension as a public health problem.
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INTRODUCTION
Hypertension is one of the main risk factors for 
cardiovascular diseases, the main cause of death(1). The 
prevalence of hypertension in Brazil, in a meta-analysis 
study covering the 1980 to 2000 period, was estimated 
to be 31% in the general population(2). According to the 
Brazilian Hypertension Guidelines, the disease can be 
classified in different stages (I, II or III), depending on 
blood pressure values and patients should be stratified 
according to the presence of additional risk factors or 
injury in target organs, in order to optimize the thera-
peutic decision(1). The high prevalence of the disease, in 
addition to the unsatisfactory control of hypertension, 
since only 30% of hypertensive patients have controlled 
blood pressure(3), and problems related to diagnosis and 
treatment, are also potential agents for lesions in target 
organs, raising the mortality rate(4).
In the United States, hypertension-related deaths 
increased 61.8% between 2000 and 2013(5) and, in an autopsy 
study, hypertensive diseases were the main cause of cardi-
ovascular death(6). However, in Brazil, there are few studies 
evaluating the association between hypertension and causes 
of death using autopsy, which is considered as gold standard 
to define the cause of death.
Therefore, this study aimed to analyze hypertension and 
its relation to the causes of deaths identified by autopsy in 
newly deceased individuals.
METHOD
Study deSign
This is a cross-sectional study.
PoPulation
The data were collect from the Brazilian Aging Brain 
Study Group, Medical School, Universidade de São 
Paulo. The Brain Bank collects clinical information with 
the informants of the deceased through a semi-struc-
tured interview composed of validated instruments for 
post-mortem research(7). Interviews are conducted by 
trained nurses. The autopsy data comes from Sao Paulo 
Autopsy Service, which verifies the cause of death by 
natural cause not established through the autopsy. The 
population was composed of people who died between 
2004 and 2014.
Selection criteria
Inclusion criteria in the Brain Bank are: 50 years of 
age and higher; death by natural causes and; have an 
informant with minimum weekly living with the deceased. 
Exclusion criteria are: death due to brain pathologies that 
make impossible the macroscopic evaluation of the brain, 
such as hemorrhagic encephalic stroke; disease responsi-
ble for causing hypoxia or cerebral hypo-flow; or history 
of prolonged cardiorespiratory arrest in the three months 
prior to death.
SamPle definition
The sample was calculated based on the prevalence of 
65% of hypertension in the Brazilian elderly population(8), 
since the deceased persons included in the Brain Bank 
were older than 50 years. Thus, a sample of 341 individ-
uals was calculated, with 356 cases being collected in 
order to cover possible data losses. In order to produce a 
representative sample of the total cases and to minimize 
the interference of the researcher, we opted for simple 
randomization. The draw was made by computer from 
the case number.
data collection
Data were collected retrospectively. The dependent 
study variable was hypertension. The criterion used to 
define hypertension was the report of the disease, by the 
informant of the deceased, as a personal antecedent in 
life and/or report of use of antihypertensive drugs. The 
independent variables were: age, sex, ethnicity (white and 
nonwhite); marital status (with partner or without part-
ner); profession (retired, with employment relationship, 
housewife, pensioner, self-employed or without occu-
pation); schooling (illiterate, incomplete elementary, 
complete elementary, high school or higher education); 
socioeconomic classification (classes A, B, C, D and E, 
defined by the Critério de Classificação Econômica Brasil 
(CCEB – Brazilian Economic Classification Criteria)). 
This stratification criterion aims to generate a standard-
ized scoring system that predicts consumption capacity of 
individuals and families, capable of discriminating large 
groups according to their capacity to consume products 
and services accessible to a significant part of the pop-
ulation(9). The comorbidities reported by the informants 
of the deceased were diabetes, coronary artery disease, 
heart failure, arrhythmia, dyslipidemia, use of pace-
maker, chronic renal insufficiency, stroke, chronic pul-
monary diseases, depression, rheumatic diseases, cancer, 
peripheral vascular disease, neurodegenerative diseases 
and infectious diseases; and family history of hyperten-
sion, acute myocardial infarction, stroke, cancer, diabetes 
and neurodegenerative diseases. The presence of depres-
sion was assessed by the Structural Clinical Interview 
for DSM Disorders – SCID(10). The life habits evaluated 
were: smoking and alcoholism (yes or no) and physical 
activity (sedentary or active). Body Mass Index (BMI) 
was obtained from the weight and height, measured with 
the deceased in the supine position without clothes, by 
a technician of the service. The drugs were classified 
according to the drug class (hypoglycemic agents, anti-
coagulants/antiplatelet, cardiotonics, psychotropic agents, 
bronchodilators, lipid-lowering agents, analgesics, gastric 
shields and antihypertensive drugs). The causes of death 
were identified at the autopsy performed by a pathologist 
and classified through the International Classification of 
Diseases and Related Health Problems (ICD-10). Causes 
of death were detailed in immediate cause, main disease 
related to death and basic cause. The autopsy begins by 
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external inspection or ectoscopy of the body. The inter-
nal examination, the next stage of the autopsy, is divided 
into an internal examination of the head (cranial cavity) 
and the trunk (thoracic and abdominal cavities) and it 
is begun by incision. The pathologist examines the body 
cavities and describes the possibility of air (pneumotho-
rax, for example). He measures the volume of fluids and 
blood, examining the integrity and limits of the anatomy, 
evaluating the external appearance of the organs and their 
location; and detects adhesions and obliteration of the 
cavities, and lesions and hemorrhages, according to the 
general principles of pathological anatomy. Samples of 
suspicious areas of organs such as kidney, spleen, lung, 
liver, heart and brain are collected for anatomopatholog-
ical analysis. A brief family report in terms of how death 
occurred, and preexisting diseases are also collected to 
confront macro and microscopic findings(11).
data analySiS and treatment
The analyzes were performed by the SPSS 22.0 statis-
tical program. The level of significance was set at 0.05. We 
used means and standard deviations of the quantitative 
variables, as well as absolute (n) and relative (%) fre-
quencies for descriptive analyzes. The association between 
categorical variables and hypertension was analyzed by 
the chi-square test or Fisher’s test, when appropriate. 
The differences between the means of the quantitative 
variables were analyzed by the t-Student test. The var-
iables associated to hypertension identified as p<0.20 
were included in the multivariate analysis, performed by 
logistic regression.
ethical aSPectS
The project was approved by the Research Ethics 
Committee of the Universidade de São Paulo School of 
Nursing, in 2016, opinion number 1.464.686. All cases 
belonging to the Brain Bank had a signed consent form. 
For the accomplishment of this study, the Guidelines and 
Norms Regulating Investigations involving Human Beings 
were followed, according to the Resolution nº. 466/2012 of 
the National Health Council(12).
RESULTS
Data from 356 deceased persons were evaluated. The 
mean age was 70.83 (11.54) years; the majority were male 
(56.2%), retired (53.7%), smoker (55.1%), sedentary (57.5%), 
white ethnicity (68%), low schooling (19% were Illiterate 
and 63% had incomplete elementary school), low soci-
oeconomic classification (71.5% in classes C, D and E); 
Considerable number had a partner (48%); and less than a 
third (28.7%) were alcoholic.
The prevalence of hypertension, reported by the inform-
ants, was 66.3%. The number of people with hypertension 
was higher in relation to non-hypertensive individuals 
(p<0.05), as most of them were female, housewives, had a 
greater number of children, and had a higher body mass 
index (Table 1).
Table 1 – Biosocial variables and habits and lifestyles in the 
deceased, according to the hypertensive and non-hypertensive 
groups, corresponding to information reported by the relative – 
São Paulo, 2004-2014.
Variable
Hypertensive Non-hypertensive p Value
N (%) N (%)
Sex
Male 121 (51.3) 79 (65.8)
0.009*
Female 115 (48.7) 41 (34.2)
Race
White 160 (67.8) 82 (68.3)
0.91†
Nonwhite 76 (32.2) 38 (31.7)
Marital status
With partner 121 (51.3) 50 (41.7)
0.08*
Without partner 115 (48.7) 70 (58.3)
Profession (N= 354)
Retired 121 (51.2) 69 (58.5)
0.001†
Employed 34 (14.4) 25 (21.2)
Housewife 46 (19.5) 8 (6.8)
Pensioner 28 (11.9) 8 (6.8)
Self-employed 7 (3.0) 6 (5.0)
No occupation 0 (0.0) 2 (1.7)
Education (N= 348)
Illiterate 49 (21.3) 17 (14.4)
0.226†
Incomplete elementary school 135 (58.7) 84 (71.2)
Complete elementary school 21 (9.1) 6 (5.1)
High school 19 (8.3) 8 (6.8)
Higher education 6 (2.6) 3 (2.5)
Socioeconomic Classification (N= 353)
A to B 72 (30.9) 29 (24.1)
0.114†
C 103 (44.2) 68 (56.7)
D 57 (24.5) 21 (17.5)
E 1 (0.4) 2 (1.7)
Smoking 131 (55.0) 65 (54.2) 0.81*
Alcoholism 60 (25.4) 42 (35.0) 0.059*
Sedentary life style 125 (57.6) 63 (57.3) 0.95*
Age, years, mean (SD) 70.67 (10.8) 71.15 (12.8) 0.713‡
BMI, Kg/m², mean (SD) 24.10 (4.33) 21.44 (4.221) <0.000‡
*χ² test; † Fisher exact test; ‡ T-Student test.
Hypertension was the most reported disease (62.9%) in 
the personal history. The other comorbidities reported were 
diabetes mellitus (28.1%), as the second most informed cause 
and, less frequently, coronary artery disease (18.8%), heart fail-
ure (14.0%) and stroke (12.9%). Depression was identified in 
15.4% of the deceased. In the family history, acute myocardial 
infarction was the most cited (28.2%), followed by cancer 
(17.3%) and hypertension (17%). The deceased hypertensives 
compared to non-hypertensive individuals presented more 
(p<0.05) personal antecedents for diabetes, coronary artery 
disease, heart failure, stroke, arrhythmia and family history 
for hypertension, but had less cancer and personal and family 
antecedent for neurodegenerative diseases (Table 2).
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Table 2 – Personal and family history of referred diseases in 
deceased persons, according to the hypertensive and non-
hypertensive groups, corresponding to information reported by 
the relative – São Paulo, 2004-2014.
Variable
Hypertensive Non-hypertensive p Value
N (%) N (%)
Personal background    
Diabetes Mellitus 81 (34.3) 19 (15.8) <0.0001*
Coronary artery disease 61 (25.4) 7 (5.8) <0.0001*
Heart Failure 44 (18.6) 6 (5.0) <0.0001*
Stroke 40 (16.9) 6 (5.0) 0.001*
Chronic renal insufficiency 29 (12.3) 12 (10.0) 0.523*
Dyslipidemia 26 (11.0) 6 (5.0) 0.061*
Cancer 12 (5.1) 16 (13.3) 0.006*
Arrhythmia 24 (9.7) 2 (1.7) 0.005*
Depression 12 (5.1) 7 (5.8) 0.766*
Vascular disease 15 (6.4) 2 (1.7) 0.051*
Neurodegenerative diseases 6 (2.5) 9 (7.5) 0.028*
Major depressive episode 41 (17.4) 14 (11.7) 0.159*
Family history
Acute myocardial infarction 56 (28.9) 27 (27.0) 0.646*
Cancer 32 (16.5) 19 (19.0) 0.453*
Hypertension 41 (21.1) 9 (9.0) 0.031*
Stroke 31 (16.0) 11 (11.0) 0.413*
Diabetes Mellitus 28 (14.4) 13 (13.0) 0.643*
Neurodegenerative diseases 5 (2.6) 11 (11.0) 0.004*
*χ² test; †Fisher exact test.
Most informants (77.5%) reported that the deceased 
person used at least one drug, with antihypertensive drugs 
being the most reported (52%). The data in Table 3 show 
the other drugs mentioned: hypoglycemic agents (17.2%), 
anticoagulants/antiplatelet agents (16.9%) and cardiotonics 
(9.8%). The hypertensive individuals were different from 
non-hypertensive individuals due to the higher use of hypo-
glycemic agents, anticoagulants/antiplatelet agents and a 
lesser use of analgesics (p<0.05).
Among those who had hypertension, 77% used some 
type of antihypertensive drug, but 43.1% of the informants 
did not know the name of the medications. Among those 
who reported the name of the drug, about half (50.2%) 
reported Angiotensin-Converting Enzyme Inhibitors 
(ACE), followed by diuretics (35.3%), in lower proportions, 
beta-blockers (11.3%), calcium channel blockers (7.1%) and 
central-acting agents (1.7%).
Table 3 – Use of drugs of the deceased, according to the 
hypertensive and non-hypertensive groups, corresponding to 
information reported by the relative – São Paulo, 2004-2014.
Variable
Hypertense Non-hypertense
p Value
N (%) N (%)
Hypoglycemic agents 48 (20.9) 10 (9.3) 0.027*
Anticoagulants/ 
antiplatelet /Antiplatelet 50 (21.7) 7 (6.5) 0.002*
Cardiotonics 26 (11.3) 7 (6.5) 0.30*
Psychotropic 15 (6.5) 8 (7.4) 0.684*
Bronchodilators 11 (4.8) 5 (4.6) 0.729*
Hipolipemiants 13 (5.7) 1 (0.9) 0.09**
Analgesics 2 (0.9) 10 (9.3) <0.0001†
Gastric shield 6 (2.6) 4 (3.7) 0.557†
*χ² test; † Fisher exact test.
Data in Table 4 show the causes of death identified by 
autopsy, present in the death certificate, described in imme-
diate cause, basic cause and main disease related to death. 
The immediate causes are illnesses or complications that 
directly caused death, while the underlying causes are dis-
eases or injuries that started the chain of morbid events and 
led directly and inevitably to death.
The analysis of the causes of death identified at the 
autopsy showed that the most frequent cause of death was 
pulmonary edema (31.1%) and, secondly, ischemic heart 
disease (25.0%). Atherosclerosis was the leading cause of 
death (37.8%), followed by hypertension (25.6%). In relation 
to the main disease related to death, ischemic heart diseases 
(19.5%) and atherosclerosis (18.8%) were the most frequent, 
and, at a lower frequency, hypertensive diseases (9.57%) and 
other forms of Heart disease (9.24%).
In the assessment of the immediate cause of death, hyper-
tensive patients died more of ischemic heart disease (28.3% 
vs 18.3%); however, hypertensive patients died with less fre-
quency of infectious diseases (10.1% vs 24.1%) and chronic 
diseases of the lower airways (2.1% vs 7.5%). Regarding the 
underlying cause of death, patients died more of hypertension 
(30.6% vs 14.6%) than of neoplasms (5.6% vs 20.8%). As to 
the main disease related to death, hypertensive patients com-
pared to non-hypertensive patients presented more ischemic 
heart diseases (23.4% vs 11.8%), atherosclerosis (22.9% vs. 
10.8%) and hypertension (8.0% vs 1.0%), but less infectious 
diseases (6% vs 13.7%) and neoplasms (3.0% vs 13.7%).
Table 4 – Causes of death obtained by autopsy in deceased persons, according to the hypertensive and non-hypertensive groups, 
corresponding to information reported by the relative – São Paulo, 2004-2014.
Variable
Hypertense Non-hypertense Total
p Value
N (%) N (%) N(%)
Immediate cause (N=356)
Pulmonary edema 79 (33.4) 32 (26.6) 111(31.1) 0.19*
Ischemic heart disease 67 (28.3) 22 (18.3) 89 (25.0) 0.03*
continues...
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Variable
Hypertense Non-hypertense Total
p Value
N (%) N (%) N(%)
Infectious diseases 24 (10.1) 29 (24.1) 53 (14.8) <0.0001*
Pulmonary 
thromboembolism 15 (6.3) 10 (8.3) 25 (7.0) 0.49*
Other forms of heart disease 16 (6.7) 3 (2.5) 19 (5.3) 0.08*
Chronic diseases of the 
lower airways 5 (2.1) 9 (7.5) 14 (3.9) 0.02
†
Hypertensive diseases 7 (2.9) 1 (0.8) 8 (2.2) 0.27†
Diseases of the digestive 
system 3 (1.2) 4 (3.3) 7 (1.9) 0.23
†
Cerebrovascular diseases 5 (2.1) 1 (0.8) 6 (1.6) 0.66†
Shock 5 (2.1) 0 (0.0) 5 (1.4) 0.17†
Basic Cause (N=156)
Atherosclerosis 45 (41.7) 14 (29.2) 59 (37.8) 0.13*
Hypertension 33 (30.6) 7 (14.6) 40 (25.6) 0.03*
Cancer 6 (5.6) 10 (20.8) 16 (10.2) 0.008*
Other forms of heart disease 7 (6.5) 4 (8.3) 11 (7.0) 0.73†
Ischemic heart disease 7 (6.5) 1 (2.1) 8 (5.2) 0.43†
Infectious diseases 5 (4.6) 2 (4.2) 7 (4.4) 1.00†
Diseases of the digestive 
system 2 (1.9) 4 (8.3) 6 (3.8) 0.07
†
Primary illness related to death (N=303)
Ischemic heart disease 47 (23.4) 12 (11.8) 59 (19.5) 0.01*
Atherosclerosis 46 (22.9) 11 (10.8) 57 (18.8) 0.01*
Hypertensive diseases 22 (10.9) 7 (6.9) 29 (9.5) 0.25*
Other forms of heart disease 18 (9.0) 10 (9.8) 28 (9.2) 0.81*
Infectious diseases 12 (6.0) 14 (13.7) 26 (8.6) 0.02*
Cancer  6 (3.0) 14 (13.7) 20 (6.6) <0.0001*
Hypertension 16 (8.0) 1 (1.0) 17 (5.7) 0.013*
Aortic aneurysm 8 (4.0) 5 (4.9) 13 (4.2) 0.76†
Pulmonary 
thromboembolism 6 (3.0) 5 (4.9) 11 (3.6) 0.51
†
Chronic diseases of the 
lower airways 4 (2.0)  5 (4.9) 9 (2.9) 0.17
†
*χ² test; † Fisher exact test.
...continuation
In the multivariate analysis, the variables that were positively 
associated with hypertension were: personal history of diabetes 
[OR = 2.39 (CI95%: 1.34-4.27)]; female [2.30 (CI95%:1.34-
3.90)] and Body Mass Index [1.14 (CI95%: 1.08-1.22)]. Living 
with a partner conferred greater chances of protection for 
hypertension [0.55 (CI95%: 0.32-0.92)] (Table 5).
Table 5 – Logistic regression model: variables associated with 
arterial hypertension – São Paulo, 2004-2014.
Variable Unadjusted OR (IC95%) Adjusted OR (CI 95%)
Sex
Male 1(reference)
Female 1.83(1.16-2.88) 2.30(1.34-3.90)
Marital status
Without partner 1(reference)
With partner 0.67 (0.43-1.05) 0.55 (0.32-0.92)
BMI 1.15(1.09-1.22) 1.14 (1.08-1.22)
Personal history of diabetes mellitus
No 1(reference)
Yes 2.77 (1.59-4.85) 2.39(1.34-4.27)
DISCUSSION
The main findings of the present study showed that 
hypertension was an important underlying cause of death, 
in addition to having a high prevalence. This prevalence is 
compatible with other findings. In Brazil, epidemiological 
studies and systematic review indicate that the prevalence 
of hypertension in the general population is around 30%(2,13). 
Data from England, United States and Canada indicate per-
centages of 30%, 29.1% and 19.5% in the general population, 
respectively; and higher rates in the elderly, of 63.7%, 53.2% 
and 63.6%, respectively(14). Research performed with the same 
population had already shown a high and similar prevalence 
(65.1%)(9), as well as in other Brazilian studies with an elderly 
population(3,15). Age was not associated with hypertension and 
remained around the seventh decade in the deceased studied, 
being able to explain the high prevalence of hypertension.
Regarding gender, which was one of the variables that 
remained in the multivariate analysis, associated with 
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hypertension, women had a chance of hypertension almost 
twice as high as men. National survey found a difference 
between the sexes only for the age group over 70 years 
(82.4% in women vs 57.1% in men, p<0.05)(16). Similarly, the 
American Heart Association identified higher prevalence 
among women aged 65 years or older compared to men of the 
same age(1). In females, possibly due to the postmenopausal 
period, in addition to the known mechanisms of pressure 
control, there is the additional effect of hormonal decline, 
which may justify these findings(17). On the other hand, a study 
showed that hypertensive women were more controlled than 
men, despite the existence of biopsychosocial variables that 
may influence negatively adherence to treatment(18).
Another important finding was that living with a part-
ner conferred lower chances for the existence of arterial 
hypertension when compared to those who did not have a 
partner. In that sense, a study showed that widows(19) had 
a 20% higher risk of having hypertension than those who 
were married, suggesting that living without a partner could 
increase the risk for the disease. The “housewife” occupation 
was not associated with hypertension in the multivariate 
analysis, but it showed a relation with hypertension in the 
bivariate analysis. This can be explained by the fact that most 
of the hypertensive population has low schooling and low 
income, characterizing the profile of people without formal 
work. Although in the present study hypertension was not 
associated with schooling or socioeconomic status, another 
study found association between low schooling and income 
with the presence of hypertension(20).
Body mass index was associated with hypertension in the 
multivariate analysis model, and the literature has reinforced 
the association between obesity and hypertension(21-22). 
Data from Brazil, from 1975 to 2003, showed an expressive 
increase in the prevalence of overweight and obesity, rep-
resenting one of the most challenging problems. Excessive 
weight and obesity are associated with morbidity, mortality, 
and significant costs in the health area(23). Therefore, weight 
loss has been associated with a decrease in terms of cardi-
ovascular complications and gain in life years(24). Physical 
activity also plays an important role in the context of car-
diovascular diseases. The performance of intense or moder-
ate physical activity for 12 months represented a sustained 
improvement in abdominal obesity and blood pressure(25). 
In the present study, hypertensive and non-hypertensive 
individuals were similar in relation to physical activity, but 
the level of sedentary lifestyle was high (57.5%). Therefore, 
changes in habits and lifestyles can positively influence peo-
ple’s health and modify the mortality profile.
Variables of the personal history of diseases, related to 
cardiovascular risk factors, presented relevant prevalence. 
Only the report of diabetes mellitus was associated with 
hypertension in the multivariate model, increasing the 
chance of hypertension more than twice. In Brazil, the 
prevalence of diabetes in a multicenter study was 19.7%; 
and 50.4% of this was not previously diagnosed and 79.1% 
presented intermediate hyperglycemia, showing the seri-
ous problem of the disease in the country(26). Regarding the 
other comorbidities that were identified, the findings were 
similar to those of the study that showed that hypertensive 
patients had a higher prevalence of dyslipidemia, chronic 
kidney disease, obesity, diabetes and cardiovascular diseases, 
including stroke, acute myocardial infarction and angina(27). 
The presence of multimorbidities in hypertensive individu-
als may contribute to potential complications for increased 
mortality. A meta-analysis study found that the reduction of 
10 mmHg in systolic pressure decreased (p<0.05) the risk of 
coronary heart disease, stroke and heart failure, as well as a 
13% reduction in all-cause mortality(28). This scenario plays 
an important role in the definition of therapeutic strate-
gies, since hypertensive patients may present complications, 
which potentially increase mortality.
Depression has not been associated with hypertension, 
although, it is an important finding, since data from the 
Longitudinal Adult Health Study (ELSA) have indicated 
that psychopathological symptoms were directly associated 
with atherosclerosis and this association appeared to be 
stronger in people with more than 50 years of age(29), age 
profile similar to that of the present study. Such associa-
tions are important to understand the relationship between 
cardiovascular diseases and psychopathological symptoms.
Regarding the causes of death, hypertension represented 
the second most frequent basic cause. It is also worth men-
tioning that other cardiac causes, such as ischemic and 
hypertensive diseases, added to hypertension, accounted 
for 41% of the basic causes of death in the sample stud-
ied. The causes of death due to hypertensive diseases have 
tended to increase in the last decades in Brazil(4) and in 
the United States, where they increased by 23.1% in the 
period from 2000 to 2013(5). The mortality trends of cardi-
ovascular diseases in the regions of the Americas, since the 
2000s, have declined by 29.5% in North America, lower falls 
(14.1%) in Latin America and a decrease of only 10.9% in 
the Caribbean region(30).
The present study presented some limitations. It is a 
transversal one, which does not allow to establish relations 
of cause and effect. Another limitation was the presence of 
death certificates with incomplete completion. In view of 
this, a detailed analysis of all the causes of death was chosen, 
aiming to better portray the mortality profile.
The advantages of the present study were the use of 
autopsy, considered gold standard in the definition of the 
cause of death and the inclusion of informants of the deceased 
persons who had minimally weekly contact with the deceased 
to reduce the information bias; in addition, the clinical inter-
view was validated for the post-mortem collection(8).
CONCLUSION
The prevalence of arterial hypertension identified in the 
present study was high, and data on death indicated that 
hypertension represented a major cause of death and was 
associated with demographic and personal antecedents. 
These results corroborate the high prevalence of the disease 
in the national scenario, showing its influence on mortal-
ity. In addition, the present study brought advances in the 
studies on arterial hypertension, when working with the gold 
standard to define the cause of death, the autopsy.
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RESUMO
Objetivo: Analisar a hipertensão e sua relação com as causas de morte identificadas pela autópsia. Método: Estudo transversal, que 
analisou 356 participantes do Biobanco para Estudos no Envelhecimento, com idade maior do que 50 anos, autopsiados no Serviço de 
Verificação de Óbitos entre os anos de 2004 a 2014. Uma entrevista clínica foi realizada com o informante do falecido. A hipertensão 
foi definida pelo relato da doença e/ou o uso de medicação anti-hipertensiva pelo informante do falecido. Foram realizadas análises 
descritivas e associações bivariadas e multivariáveis. Resultados: A prevalência de hipertensão arterial foi de 66,2% e foi a segunda causa 
básica de óbito (25,6%) identificada na autópsia, precedida de aterosclerose (37,8%). As variáveis associadas à hipertensão foram: gênero 
feminino (OR = 2,30 (1,34-3,90); ter um parceiro [OR = 0,55 (0,32-0,92)]; índice de massa corporal [OR = 1,14 (1,08-1,22)] e história 
de diabetes [OR = 2,39 (1,34-4,27)]. Conclusão: A prevalência de hipertensão foi elevada e representou a segunda causa básica de óbito 
mais frequente. O uso da autópsia como padrão-ouro para definir a causa da morte confirmou a relevância da hipertensão como um 
problema de saúde pública.
DESCRITORES
Hipertensão; Causa de Morte; Mortalidade; Autópsia.
RESUMEN
Objetivo: Analizar la hipertensión y su relación con las causas de muerte identificadas por la autopsia. Método: Estudio transversal, 
que analizó a 356 participantes del Biobanco para Estudios en el Envejecimiento, con edad mayor a 50 años, autopsiados en el Servicio 
de Verificación de Defunciones entre los años 2004 y 2014. Una entrevista clínica fue realizada con el informante del fallecido. La 
hipertensión fue definida por el relato de la enfermedad y/o uso de medicación antihipertensiva por el informante del fallecido. Se 
llevaron a cabo análisis descriptivos y asociaciones bivariadas y multivariables. Resultados: La prevalencia de hipertensión arterial fue del 
66,2% y fue la segunda causa básica de defunción (25,6%) identificada en la autopsia, precedida de aterosclerosis (37,8%). Las variables 
asociadas con la hipertensión fueron: género femenino (OR = 2,30 (1,34-3,90); tener a una pareja [OR = 0,55 (0,32-0,92)]; índice de 
masa corporal [OR = 1,14 (1,08-1,22)] e historia de diabetes [OR = 2,39 (1,34-4,27)]. Conclusión: La prevalencia de hipertensión fue 
elevada y representó la segunda causa básica de defunción más frecuente. El uso de la autopsia como regla de oro para definir la causa 
de la muerte confirmó la relevancia de la hipertensión como un problema de salud pública.
DESCRIPTORES
Hipertención; Causas de Muerte; Mortalidad; Autopsia.
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